Edesa Biotech, Inc. (EDSA) Form 424B3 — Jul 13, 2026
Edesa Biotech filed a prospectus relating to the resale of up to 729,241 common shares by selling shareholders who participated in a private placement that closed in June 2026. The company will not receive any proceeds from this resale, which is intended to provide liquidity to the investors. The shares being registered were issued to institutional investors and the company's Chief Executive Officer at purchase prices of $4.69 and $5.21 per share, respectively. As of the filing date, the last reported sale price on the Nasdaq Capital Market was $7.01 per share, indicating potential profit for the selling shareholders.
Key figures
- Shares Offered
- 729241
- Shares Outstanding
- 9633223
- Last Reported Sale Price
- $7.01
- Private Placement Price CEO
- $5.21
- Private Placement Aggregate
- $3.5 million
- Private Placement Price Investors
- $4.69
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.